Human ApoB quantitates human ApoB in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ApoB.
Accession number
Aa1064 ; Ac1-060 ; AI315052 ; Apo B100 ; Apo B-100 ; Apo B-48 ; Apob ; apo-B ; ApoB-100 ; apob-48 ; apolipo b ; apolipoprotéine B ; apolipoprotéine B (y compris l’antigène Ag(x)) ; apolipoprotéine B PI ; apolipoprotéine B100 ; apolipoprotéine B-100 ; apolipoprotéine B46 ; apolipoprotéine B47 ; apolipoprotéine B48 ; apolipoprotéine B-48 ; apolipoprotéine B49 ; FLDB ; LDLCCQ4 ; LOX-1 ; mCG_129875 ; MGC176318 ; récepteur Ox-LDL 1
Dose range
0.21 to 50 ng/ml
Sensitivity of the dosage
0.21 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human ApoB quantitates human ApoB in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ApoB.
Human ApoB quantitates human ApoB in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ApoB.
L-apolipoprotein B (apo B) in human plasma is a major low-density lipoprotein (LDL) protein with a molecular mass of approximately 260-500 kDa. L-apolipoprotein B binds to specific receptors on cell membranes and is involved in the elimination of LDL cholesterol and very low-density lipoproteins (VLDL) from circulation. Low density lipoprotein (LDL) is the protein that carries cholesterol in the blood. LDL binds to its receptor on the capillary walls and, therefore, media l-absorption and clearance of cholesterol in circulation. In atherosclerotic lesions, oxidatively modified LDL and oxidized LDL are specifically recognized and ingested by macrophages via the A and CD36 garbage receptors. The oxidized LDL may be a marker of the atherosclerosis, but precise changes in oxidized LDL are not well described. LDL oxidized by MDA appears to be different from LDL oxidized by other means. L-apolipoprotein B is mainly synthesized in the liver and constitutes a major apolipoprotein of very low density, intermediate density and low density lipoproteins (LDL) and a major component of lipoprotein (a). The ligand for the LDL receptor is a ligand, and high levels are associated with premature atherosclerosis. The normal plasma levels of apolipoprotein B are approximately 800 mg/l. The plasma is found in the plasma as two main isoforms, the apoB-48 and the apoB-100. Intestinal and hepatic forms of apolipoprotein B are encoded by a single gene from a single very long mRNA. Both isoforms share a common N-terminal end sequence. The shortest apoB-48 protein was produced after RNA was published from the transcript of the apoB-100 to the 2180 (CAA->UAA) residue, resulting in the creation of a shut-down codon and the termination of early translation. Mutations of the gene of l的apolipoprotein B or its regulatory region cause hypobetalipoproteinemia, hypobetalipoproteinemia normotriglyceridaemic and hypercholesterolaemia due to ligand deficiency apolipoprotein B, diseases affecting plasma cholesterol and B-apolipoprotein levels.
Sensitivity
Sensitivity of the dosage: 0.21 ng/ml.
Measurement range
Dose range: 0.21 to 50 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Apolipoprotein B.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
16642003
Specifications
Accession number
Aa1064; Ac1-060; AI315052; Apo B100; Apo B-100; Apo B-48; Apob; apo-B; ApoB-100; apob-48; apolipo b; apolipoprotein B; apolipoprotein B (including Ag(x) antigen); apolipoprotein B PI; apolipoprotein B100; apolipoprotein B-100; apolipoprotein B46; apolipoprotein B47; apolipoprotein